Caner Immunotherapy Pilot Program News Today

October marks the start of a new fiscal year for the USPTO. Last week the agency announced the extension of several pilot programs that will continue on into 2023 and beyond.

The Caner Immunotherapy Pilot Program/Patents 4 Patients program has been extend through January 31, the Fast-Track Appeals Pilot Program has been extended through July 2, 2024, and the After Final Consideration Pilot AFCP Program 2.0 has been extended to September 30, 2023

October marks the start of a new fiscal year for the USPTO.